Staphylococcus epidermidis are a member of coagulase negative gram-positive bacteria, which are known as a common human microbiota and cause infections in hospitalized patients (
1).
Staphylococcus epidermidis are opportunistic pathogens, which lack virulence factors and are known as the most important cause of indwelling device-related infections (
2).
Staphylococcus epidermidis has the ability to form biofilm, which consists of multilayered bacterial communities stabilized by intercellular adhesive mechanisms that do not respond to antimicrobial treatments (
3).
Staphylococcus epidermidis binds to extracellular matrix proteins via microbial surface components recognizing adhesive matrix molecules (MSCRAMMS) (
4). Currently, the best understood biofilm mechanism in
S. epidermidis is synthesis of major component of exopolysaccharide matrix, polysaccharide intercellular adhesion (PIA) or Polymeric N-Acetyl-Glucosamine (PNAG) (
2,
5). Adhesion factors, such as intercellular adhesin locus (
ica) composed of genes
icaA,
icaD,
icaB and
icaC, which code for polysaccharide intercellular adhesin (
PIA) and biofilm associated-homologous protein (
bhp) play an important role in the ability of
S. epidermidis to persist and form multilayered bacterial communities (
6,
7). It has been shown that prevalence of
ica locus among clinical
S. epidermidis strains isolated from catheter-related infections and sepsis is higher than other sources (
8,
9). In strains that lack the
ica locus, biofilm formation is due to the presence of
aap gene, which enables bacteria to bind to various matrix proteins (
5). Insertion of transposon IS
256 into the
ica locus results in change of biofilm formation and resistance to aminoglycosides, which converts biofilm positive to biofilm negative bacteria (
9,
10).
Biofilm communities show high-level resistance to antimicrobial agents, which is due to reduced cell division, DNA replication and synthesis of different proteins (
5). Moreover, biofilm results in recurrent infections, which are difficult to treat and lead to higher treatment costs (
3).